Le Lézard
Classified in: Health
Subject: AWD

Keith Ablow, MD, Selected as Chairman of the Classics of Psychiatry & Behavioral Sciences Library by Gryphon Editions


BOSTON, July 20, 2018 /PRNewswire/ -- Keith Ablow, MD, New York Times and USA Today bestselling self-help author, has announced that readers can now pre-order signed, leather-bound, limited edition copies of his work To Wrestle with Demons, selected as the lead title of the Classics of Psychiatry & Behavioral Sciences Library, published by Gryphon Corporation.

Dr. Keith Ablow was also selected by Gryphon Corporation as Chairman of their series of classic volumes by the world's leading psychologists and psychiatrists.

Dr. Ablow was the host of the nationally-syndicated Dr. Keith Ablow Show, has appeared hundreds of times on Oprah, the Today Show, Good Morning America, CBS This Morning, Fox and Friends and Inside Edition and is a national leader on new treatments for depression, anxiety disorders, addiction, Lyme Disease and attention deficit disorder.  

"To Wrestle with Demons takes readers inside the practice of psychiatry and gives them rare insight into the workings of the human mind, human relationships and the brain," Ablow said. "I am honored and humbled by these beautiful volumes created by Gryphon Editions."

Dr. Keith Ablow has been called one of the 5 most influential psychiatrists alive (GESciencePrize.org) and one of the 35 most famous psychiatrists to ever live (Ranker.com). He treats patients around the world, whether in person or through telemedicine (e.g. Skype).

To reserve copies of Dr. Ablow's To Wrestle with Demons, call 888-655-0134.

To learn more about Dr. Ablow's practice of adult, adolescent and forensic psychiatry, visit www.keithablow.com.

SOURCE Keith Ablow


These press releases may also interest you

at 19:40
ReNAgade Therapeutics, a company unlocking the limitless potential for RNA medicines, today announced its ongoing commitment to exploring the therapeutic opportunity of glycobiology through support for ongoing research at GanNA Bio, and the...

at 19:05
Appili Therapeutics Inc. (the "Company" or "Appili"), a biopharmaceutical company focused on drug development for infectious diseases and medical countermeasures, today announced it has secured additional bridge financing in the amount of C$300,000...

at 19:00
David J. Dykeman, co-chair of the Life Sciences & Medical...

at 18:30
Aspire Health Alliance ("Aspire Health") is a company headquartered in Braintree, Massachusetts, that provides behavioral health services in the community.  Aspire Health experienced a data security incident that may have involved personal and...

at 17:21
Chemistree Technology Inc. (US OTC: CHMJF) (the "Company" or "Chemistree"), is pleased to announce that the adjourned extraordinary meeting of the holders of the 10% senior unsecured convertible debentures of the Company (the "Debentures") was...

at 17:15
Summary Product: Counterfeit Viagra, 100 mg sildenafil tabletsIssue: Health products - Product safety, Unauthorized productWhat to do: Immediately stop using and safely dispose of this product. Consult your health care provider if you have taken this...



News published on and distributed by: